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Subtle Pleural Metastasis without Large
Effusion in Lung Cancer Patients:
Preoperative Detection on CT
Objective: We wanted to describe the retrospective CT features of subtle pleur-
al metastasis without large effusion that would suggest inoperable lung cancer.
Materials and Methods: We enrolled 14 patients who had open thoracotomy
attempted for lung cancer, but they were proven to be inoperable due to pleural
metastasis. Our study also included 20 control patients who were proven as hav-
ing no pleural metastasis. We retrospectively evaluated the nodularity and thick-
ening of the pleura and the associated pleural effusion on the preoperative chest
CT scans. We reviewed the histologic cancer types, the size, shape and location
of the lung cancer and the associated mediastinal lymphadenopathy.
Results: Subtle pleural nodularity or focal thickening was noted in seven
patients (50%) having pleural metastasis and also in three patients (15%) of con-
trol group who were without pleural metastasis. More than one of the pleural
changes such as subtle pleural nodularity, focal thickening or effusion was identi-
fied in eight (57%) patients having pleural metastasis and also in three patients
(15%) of the control group, and these findings were significantly less frequent in
the control group patients than for the patients with pleural metastasis (p = 0.02).
The histologic types of primary lung cancer in patients with pleural metastasis
revealed as adenocarcinoma in 10 patients (71%) and squamous cell carcinoma
in four patients (29%). The location, size and shape of the primary lung cancer
and the associated mediastinal lymphadenopathy showed no significant correla-
tion with pleural metastasis.
Conclusion: If any subtle pleural nodularity or thickening is found on preopera-
tive chest CT scans of patients with lung cancer, the possibility of pleural metas-
tasis should be considered.
he diffuse pleural involvement of malignancy in lung cancer is an indica-
tor of a very poor prognosis, and such patients usually show little
sensitive to chemotherapy with the only exception being those patients
that have small cell carcinoma.
Malignant cells can exist in the pleural cavity without any pleural fluid collection or
there can be no visible indications of pleural tumor seeding on the cytology examina-
tion (1). Furthermore, unnecessary thoracotomy is sometimes performed in this group
of patients. The presence of malignant cells in the pleural cavity of patients without
pleural effusion may be attributed to either exfoliation from tumors abutting the
pleural surface and so this represents localized disease, or this may represent dissemi-
nated disease (2). If malignant cells are found in the pleural cavity of patients who
have otherwise early stage lesions, it may signify a much more aggressive tumor
biology (2).
In this paper, we retrospectively describe the CT features of pathologically proven
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Tsubtle pleural metastases that were without or with a small
amount of associated pleural effusion on preoperative
chest CT scans, and these finding can suggest T4 or M1
inoperable lung cancer.
MATERIALS AND METHODS
From December 1995 to March 1999, we experienced
14 patients who had open thoracotomy attempted for lung
cancer, but these were proven to be inoperable cases due
to pleural metastasis on the gross operative findings and
subsequent pathologic examinations. Ten of the patients
were women and four of the patients were men. The mean
age of patients was 61 years (range: 38 74 years). None
of the 14 patients had a history of previous thoracotomy or
other thoracic diseases.
Preoperative percutaneous transthoracic needle biopsy
of a primary lung mass was performed in nine patients, and
bronchoscopic biopsy was done in five patients. All 14
patients underwent preoperative chest CT scanning and
most of the chest CT scans was obtained before the
preoperative transthoracic procedures, except for two
patients. Yet in those two patients, no definite evidence of
pleural changes was noticed on chest radiographs that were
obtained before the procedures. The time interval between
the preoperative transthoracic procedures and the CT scan
was one and five days in those two patients, respectively.
Open thoracotomy with pleural biopsy was performed in
all 14 patients. The interval between the chest CT scan and
surgery was from five to 46 days (mean interval: 18.6
days). Intraoperative pleural lavage just after open
thoracotomy was performed in only two patients.
We also included 20 control patients who had undergone
operation for lung cancer during the same period, and 20
these patients were proven to have no pleural metastasis
on the pathologic findings. We included these control
patients because we wanted to compare their findings with
the frequency and significance of the retrospective findings
on chest CT scan in our study group. The control group
included five female patients and 15 male patients. The
mean age of control group was 62 years (range: 40 79
years). None of the patients of the control group had a
history of previous thoracotomy.
Preoperative percutaneous transthoracic needle biopsy
of a primary lung mass was performed in 12 patients of
control group, and bronchoscopic biopsy was done in eight
patients. All 20 patients of the control group underwent
preoperative chest CT scanning. The interval between the
chest CT scan and surgery was from three to 41 days
(mean interval: 14.5 days). Intraoperative pleural lavage
was not performed in any of the control group patients.
We retrospectively reviewed the operative findings and
pathology records of all 14 patients with pleural metastasis
and also the 20 patients of the control group. We reviewed
the gross findings on the surgical field, the pathologic
results of the pleural biopsy obtained with open thoraco-
tomy, and the histology of the primary lung cancer
obtained through either preoperative percutaneous
transthoracic needle biopsy or bronchoscopic biopsy.
All the 14 patients with pleural metastasis and the 20
patients of the control group underwent preoperative chest
CT scanning. The pre-contrast and post-contrast enhanced
chest CT scans were performed in all patients with a
Somatom plus scanner (Siemens, Erlangen, Germany) and
a CT W2000 (Hitachi Medical, Tokyo, Japan). Ten-milli
meter collimation sections were obtained through the
thorax at 8-mm intervals and with a pitch of one. The
technical factors used were 120 140 kVp and 170 250
mA. The images were reconstructed using a standard
algorithm. A limited number of thin-section CT scans were
obtained for all 14 patients and also for the 20 control
group patients before contrast enhancement, and image
reconstruction was performed with a high spatial
frequency algorithm for parenchymal analysis. The techni-
cal factors we used included 140 kVp, 170 mA and a 1.0-
sec scanning time. Two chest radiologists retrospectively
reviewed the preoperative chest CT scans and then a
consensus was reached. We evaluated such pleural changes
as the nodularity of the fissures or the costal pleural
surface, pleural thickening, the presence or absence of
pleural effusion, and the amount of pleural effusion, if any,
that was detected. We reviewed the preoperative chest CT
scans for the size, shape and location of the primary lung
tumor. We regarded tumors as being either central or
peripheral lung cancers when the major part of each tumor
was located within or beyond the division of the subseg-
mental bronchus, respectively. We also evaluated the
presence or absence of any associated mediastinal
lymphadenopathy.
RESULTS
According to the gross operative findings in the patients
with pleural metastasis, diffuse pleural nodularity ipsilat-
eral to the primary malignancy was seen in 12 patients
(86%) and foci of seeded pleural nodules or masses were
seen in the remaining two patients (14%). A small amount
of associated pleural effusion was noted in two patients
(14%) at the time of surgery.
All the pathologic results of the pleural biopsies obtained
from the 14 patients with pleural metastasis at the time of
open thoracotomy were positive for malignancy. The
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adenocarcinoma in 10 patients (71%) and as squamous cell
carcinoma in four patients (29%).
On the retrospective review of the preoperative chest CT
scans in the patients with pleural metastasis, subtle
nodularity of the fissures or of the costal pleural surfaces
ipsilateral to the malignancy was found in five patients
(36%) (Fig. 1). Ipsilateral subtle focal thickening of the
pleura or plaque-like pleural lesions found either adjacent
to (Fig. 2) or apart from (Fig. 3) the primary lung mass
were noted in three patients (21%). Subtle pleural
nodularity or focal pleural thickening ipsilateral to the
malignancy was noted in seven (50%) of the 14 patients. A
small amount of pleural effusion (less than 5 mm
maximum thickness on the CT scan) ipsilateral to the
primary malignancy (Fig. 4) was noted in four patients
(29%). Consequently, more than one of the above pleural
changes, such as pleural nodularity, focal thickening or a
small amount of pleural effusion ipsilateral to the
malignancy was retrospectively detected in eight patients
(57%), although these findings were not reported on the
preoperative evaluations. The remaining six (43%) of our
14 patients revealed none of above pleural changes upon
retrospective review of the preoperative chest CT scans.
The findings on the preoperative chest CT scans and the
CT staging of the primary lung cancers in patients with
pleural metastasis are summarized in Table 1. The mean
maximum diameter of the primary lung cancers was about
3.9 cm (range: 2.5 6.0 cm). The shape of the primary lung
masses was spiculated or lobulated in 11 cases (11/14) and
there were indistinct peripheral margins in three (3/14)
cases. The locations of primary lung masses were central in
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Fig. 1. Preoperative chest CT scans in a 37-year-old man with adenocarcinoma.
A. Lung cancer is centrally located in the right middle lobe with mild contour bulging of the abutting interlobar fissure (arrows). The right
minor fissure shows mild nodular thickening on the thin-section CT scan (arrowheads).
B. The more inferior portion of the right major fissure is also thickened with nodularity (arrowheads). Open thoracotomy revealed diffuse
nodularity of the pleura, and pleural metastasis was proven on biopsy.
AB
Fig. 2. Preoperative chest CT scans in a 74-year-old man with adenocarcinoma.
A. There is a primary lung cancer with spiculated peripheral margin in the left upper lobe.
B. On the mediastinal window scan, plaque-like focal pleural thickening is noted in the mediastinal pleura (arrows) apart from the primary
lung mass. Pleural metastasis of lung cancer was pathologically confirmed on open thoracotomy with biopsy.
ABsix patients (43%) and peripheral locations were seen in
the remaining eight patients (57%). Regarding the preoper-
ative CT staging of the primary lung tumors, one patient
(7%) had T1 staging, 12 patients had T2 staging (86%),
and one patient had T3 staging (7%). N staging of the lung
cancers on CT revealed N0 in eight (57%) patients, N1 in
one (7%) and N2 in five patients (36%) patients. No
evidence of distant metastasis to other organs was identi-
fied on the preoperative chest CT scans. The size, shape
and location of the primary lung cancers and associated
mediastinal lymphadenopathy revealed no significant
correlation with pleural metastasis.
On the pathologic review of the control group patients
having lung cancer without pleural metastasis, the
histologic types of primary lung cancer were revealed as
adenocarcinoma in 10 patients (50%) and squamous cell
carcinoma in 10 patients (50%).
On retrospective review of the preoperative chest CT
scans for the 20 patients of the control group with no
pleural metastasis, focal pleural thickening or plaque-like
pleural lesion was not noted in any of the patients. Instead,
only focal pleural tags or pleural retraction abutting to the
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Fig. 4. Preoperative chest CT scans in a 68-year-old woman with squamous cell carcinoma.
A. There are luminal obliteration of the left upper lobar bronchus due to a central lung cancer and obstructive atelectasis in the distal
lung.
B. Small amount of left pleural effusion (arrows) is noted without any evidence of pleural nodularity or thickening. Pleural metastasis of
lung cancer was proven on cytologic examination performed through open thoracotomy.
AB
Fig. 3. Preoperative chest CT scans in a 67-year-old man with adenocarcinoma.
A. On the lung window scan, there is a cavitary peripheral lung cancer in the right upper lobe.
B. There is focal plaque-like pleural thickening in the right posterior costal pleura (arrows) apart from the primary lung mass. Multifocal
pleural thickening was also noted in the remaining areas (not illustrated).
ABperipheral primary lung mass was noted in 12 patients
(60%). Focal nodularity of the pleura or fissure was noted
in three patients (15%) and all of them were also closely
abutting to the primary lung mass. A small amount of
pleural effusion ipsilateral to the primary malignancy was
seen in one patient (5%). Consequently, more than one of
the above pleural changes such as pleural nodularity, focal
thickening or a small amount of pleural effusion ipsilateral
to the malignancy was retrospectively noted in three of the
20 patients (15%) of the control group. Either the ipsilat-
eral pleural nodularity or the focal pleural thickening
adjacent to or apart from the primary lung cancer was
noted to be significantly less frequent on the preoperative
chest CT scans of the control group with lung cancer and
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Table 1. Findings on Preoperative Chest CT Scans and the CT Staging of Primary Lung Cancer with Pleural Metastasis
Age Sex
Primary Tumor CT Staging Pleural Changes on CT
Size (cm) Margin Location Histology T N Nodularity Thickening Effusion
56 F 3 3 4 I C SqcCa T2 N0 ( )( )( )
57 F 2.5 2 3 S/L P AdenoCa T2 N0 (+) ( ) (+)
69 F 2.5 2 3 S/L P AdenoCa T2 N0 (+) ( )( )
67 M 3.5 3 3 S/L P SqcCa T2 N2 (+) (+) ( )
72 F 4 3 5 L C AdenoCa T2 N1 ( )( ) (+)
64 M 6 4 3 L C SqcCa T3 N2 ( ) (+) (+)
38 M 3 2 2 I P AdenoCa T2 N0 (+) ( )( )
49 F 3 3 5 S/L C AdenoCa T2 N2 ( )( )( )
71 F 3 2.5 4 S/L P AdenoCa T2 N2 ( )( )( )
66 F 3 3 3 I C SqcCa T2 N2 ( )( ) (+)
61 F 3 3 3 S/L P AdenoCa T2 N0 ( )( )( )
74 M 3 2.5 6 S/L P AdenoCa T2 N0 ( )( )( )
66 F 2.5 2 2 S/L P AdenoCa T1 N0 ( ) (+) ( )
40 F 3 3 2 S/L p AdenoCa T2 N0 ( )( )( )
Note. AdenoCa = adenocarcinoma, C = central, I = indistinct, P = peripheral, S/L = spiculated/lobulated, SqcCa = squamous cell carcinoma, (+) = yes, ( = no.
Table 2. Findings on the Preoperative Chest CT Scans and the CT Staging of Primary Lung Cancer without Pleural Metastasis
Age Sex
Primary Tumor CT Staging Pleural Changes on CT
Size(cm) Margin Location Histology T N Nodularity Thickening Pleural tag Effusion
50 M 1.9 1.1 1.6 S/L P SqcCa T1 N0 (+) ( ) (+) ( )
60 F 3.2 2.1 3 S/L C AdenoCa T2 N0 ( )( ) (+) ( )
40 F 2 2 2.4 S/L P AdenoCa T1 N0 ( )( )( )( )
62 M 4.5 4.3 3.7 S/L P AdenoCa T2 N2 ( )( )( )( )
62 M 2 1.7 2.1 S/L P SqcCa T1 N0 ( )( )( )( )
70 M 6 5 3.5 S/L C SqcCa T3 N2 ( )( )( )( )
70 M 4.2 4.1 3.5 S/L P AdenoCa T2 N2 (+) ( ) (+) ( )
58 M 2.5 2.3 2 S/L C SqcCa T3 N0 ( )( )( )( )
79 M 5 4 4.5 S/L P SqcCa T2 N1 (+) ( ) (+) (+)
62 M 2 1.5 2 S/L P AdenoCa T1 N0 ( )( ) (+) ( )
59 M 2 1.7 2 S/L P BAC T1 N2 ( )( ) (+) ( )
57 F 1.8 1.2 2 S/L P AdenoCa T1 N0 ( )( ) (+) ( )
74 F 3 2 3 S/L P BAC T2 N0 ( )( )( )( )
69 M 7 5 6.5 S/L C SqcCa T3 N2 ( )( ) (+) ( )
64 M 7 5 6.5 S/L P SqcCa T2 N0 ( )( )( )( )
51 M 4 6 3 S/L C SqcCa T3 N0 ( )( )( )( )
70 M 3 2 3 S/L P BAC T2 N2 ( )( ) (+) ( )
59 M 3 3 2.5 S/L P BAC T2 N0 ( )( ) (+) ( )
52 F 3 2.3 2 S/L C SqcCa T2 N1 ( )( ) (+) ( )
58 M 5 4.5 4 S/L C SqcCa T2 N0 ( )( ) (+) ( )
Note. AdenoCa = adenocarcinoma, C = central, I = indistinct, P = peripheral, S/L = spiculated/lobulated, SqcCa = squamous cell carcinoma, (+) = yes, ( ) = no.there was no pleural metastasis as compared with the
patients with lung cancer and pleural metastasis (p = 0.03).
The findings on the preoperative chest CT scans and the
CT staging of the primary lung cancers in the 20 control
group patients without pleural metastasis are summarized
in Table 2. The mean maximum diameter of the primary
lung cancers was about 3.7 cm (range: 1.8 7 cm). The
shape of the primary lung masses was spiculated or
lobulated in all 20 control patients. The locations of
primary lung masses were central in seven control patients
(35%) and peripheral in the remaining 13 control patients
(65%). Regarding the preoperative CT staging of the
primary lung tumors, there was T1 staging in six patients
(30%), T2 in 10 patients (50%), and T3 in four patients
(20%). N staging of the lung cancers on CT revealed N0 in
12 patients (60%), N1 in two patients (10%), and N2 in six
patients (30%). No evidence of distant metastasis to other
organs was identified on the preoperative chest CT scans
of the control group.
DISCUSSION
Surgical resection provides the most reliable opportunity
for curing primary lung cancer, especially in the early
stages of the disease. However, discovering pleural tumor
seeding in patients with primary lung cancer is considered
an ominous sign and this is regarded as T4 or M1 disease.
Tumor seeding of the pleura in patients with primary lung
cancer is usually found to accompany frank malignant
pleural effusion and this is treated using such conservative
methods as tube thoracostomy, chemical pleurodesis,
and/or pleurectomy (3 5). Curative resection cannot be
performed for T4 lung cancer. Furthermore, incomplete
resection of T4 lung cancers does not prolong the survival
time, but can contribute to a significant increase of the
hospital mortality (6).
Until now, only malignant pleural effusion was included
in the TNM classification as a T4 spread of lung cancer.
However, we sometimes discover pleural dissemination of
malignancy at the time of thoracotomy for patients with
presumed resectable lung cancer. In most of these patients,
there is little or no associated pleural effusion, and this
makes the preoperative detection of the intrapleural
dissemination of malignancy more difficult (7). There have
been many efforts to investigate the factors contributing to
the occurrence of pleural tumor seeding that happens with
or without a small amount of pleural effusion, and to
evaluate the prognostic significance of these factors (1, 2,
8, 9, 10). Kondo et al. (1) have explained that the pleural
cavity is a lymphatic space and that the exfoliation of
cancer cells into the pleural cavity occurs not only when
the tumor is exposed on the pleural surface, but also when
the subpleural lymphatics are invaded by the tumor, even
if there is no blockage of the lymphatic drainage to the
mediastinal lymph nodes that would cause the accumula-
tion of significant pleural effusion. Therefore, pleural
metastases do not precisely coincide with effusion at the
same location (2). Panadero et al. (8) have suggested two
mechanisms of malignant pleural tumor involvement: a)
direct invasion from a neighboring tumor, and b) vascular
invasion that’s macroscopically detectable as pulmonary
arterial tumor emboli or microscopic vascular invasion that
occurs at the level of the primary tumor (8). They also
found that the parietal pleura were less frequently
involved in the metastatic process than the visceral pleura
(8). This was true not only for cases of bronchopulmonary
cancer, but also for those cancers of an extrapulmonary
origin as well (9, 10). They also suggested that the tumor
cells will first spread from the lungs to the visceral pleura
and will then produce neoplastic implants that would cast
off cells to the pleural cavity and next give rise to
secondary tumor implants in the parietal pleura and the
diaphragm (8). Willis (11) has suggested a similar
“sedimentary” mechanism of pleural metastasis.
For those cases of pleural metastasis without large
effusion in patients with primary lung cancer, the preoper-
ative radiographic detection of pleural changes indicating
pleural dissemination of malignancy is important for tumor
staging so as unnecessary thoracotomy can be avoided. CT
scanning appears to be an effective diagnostic method in
those cases of equivocal T4 lung cancer (12, 13). However,
recent reports have suggested that CT scanning is of
limited predictive value in the cases of T3 and T4 tumors
(6, 14, 15) and there have been few reports about
predictable CT findings in those cases of pleural metastases
without large effusion.
With our retrospective review of the preoperative chest
CT scans of 14 patients with primary lung cancer that were
proven at the time of open thoracotomy to be T4 or M1
stage disease due to pleural metastasis, the presence of
subtle pleural nodularity or focal pleural thickening ipsilat-
eral to the malignancy was noted in seven (50%) of the 14
patients. On the other hand, on retrospective review of the
preoperative chest CT scans for 20 control group patients
with no pleural metastasis, focal pleural thickening or
plaque-like pleural lesion was not noted in any of the
patients, and focal nodularity of the pleura or fissures was
noted in only three patients (15%). Although this was a
subtle finding that was only retrospectively identified in
our study, the presence of either ipsilateral pleural
nodularity or focal pleural thickening adjacent to or apart
from the primary lung cancer was a significantly frequent
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lung cancer (p = 0.03).
It has been reported that pleural nodularity or fissural
thickening is indicative of pleural metastases even in the
absence of pleural effusion (16), and similar diagnoses for
these findings have also been suggested in previous reports
(17, 18). Mori et al. (18) suggested the diagnostic criteria
for suspected pleural dissemination of lung cancer on CT
images; these criteria included irregular convexities and
concavities measuring up to several millimeters at the
costal and mediastinal pleural surfaces. They also prospec-
tively compared the usefulness of thick-section (10-mm
collimation, pitch 1) and thin-section (2-mm collimation,
pitch 1) helical CT scanning for the diagnosis of pleural
dissemination of tumor in patients with adenocarcinoma of
the lung. They concluded that thin-section helical CT scans
provide more useful information than the thick-section
helical CT scan for the evaluation of pleural dissemination
in lung cancer patients (13). Yamada et al. (19) have also
suggested the presence of irregular pleural thickening and
small nodules at the interlobar fissure on the thin-section
(with a slice thickness of 2 mm) chest CT scans as the
diagnostic criteria for identifying pleural tumor dissemina-
tion. Their diagnostic rate of CT scanning was 89% with a
sensitivity of 89%, a specificity of 100%, and an accuracy
of 99% (19). In a few cases of our study group, subtle
nodular thickening of the interlobar fissures was better
delineated on the thin-section images, but the number of
those cases was too limited for statistical analysis.
It is well known that adenocarcinoma of the lung shows
a higher incidence of pleural tumor seeding than does
squamous cell carcinoma (6). Eagan et al. (20) found that
positive cytology of pleural lavage after resection for lung
cancer seems to be related to the primary lung cancer cell
type, i.e. adenocarcinoma more so than other types.
Kjellberg et al. (2) also found that positive pleural cytology
before lung resection has a significant correlation with
adenocarcinoma as compared to squamous cell carcinoma
(2). Our study supports those results, and the histology of
the primary lung cancer in our patients revealed a high
percentage of adenocarcinoma, as was seen in 10 (71%) of
our 14 patients with pleural metastasis. Our study also
revealed a high prevalence of pleural metastasis in women
(10/14), and the histology of lung cancer in those patients
showed as adenocarcioma in eight patients and squamous
cell carcinoma in remaining two. We propose that these
findings can reflect increasing incidence of lung cancer in
the general population and especially in women, and
adenocarcinoma is the most prominent histological type of
lung cancer.
Several studies have suggested good utility for perform-
ing intraoperative pleural lavage either before or after
resection of lung cancer in order to determine the
importance of positive pleural cytology as a prognostic
factor (1, 2, 8, 9, 20). However, pleural lavage in those
lung cancer patients who are without pleural effusion and
who are undergoing potentially curative resection has not
yet been established as a routine staging practice.
Video-assisted thoracoscopic surgery (VATS) is assuming
an increasingly important role in the diagnosis and
treatment of various diseases of the thorax (21). One of the
most outstanding features of VATS is that it is the only
modality that allows for complete visualization of the
pleural space (21 25). This is especially important when
subtle findings can indicate pleural dissemination of
malignancy or a small amount of pleural effusion is
suspected on preoperative chest CT scanning (21 25). In
addition, VATS can allow for various interventional
procedures, e.g. biopsy of a suspected pleural lesion or of a
swollen lymph node and aspiration of a small amount of
pleural effusion (21 25). Recent reports have suggested
that preoperative VATS exploration can identify inopera-
ble factors that cannot be found on routine check-up and
thus, this procedure can be of significant benefit as compli-
cated and painful thoracotomy can be avoided (21 25).
Yet we think that the cost effectiveness of this procedure
according to the outcomes should be proven in future
studies. Further, the use of PET (positron emission
tomography) or PET-CT scanning in the staging of lung
cancer has increased dramatically (26, 27). Reports are
beginning to surface for the detection of tiny lesions, on
the order of a few millimeters. We think that PET or PET-
CT scanning likely would have been a positive diagnostic
addition for some of our study patients.
Our study has some limitations. First, this study was
retrospectively performed with a relatively small number
of the cases, and the radiologists who reviewed the cases
were not completely blinded to the surgical results.
Second, we could not directly correlate the CT findings
with the findings at surgery. However, we think this not so
important because diffuse dissemination of pleural
nodularity ipsilateral to the primary malignancy was seen
on the gross operation field in many (12/14, 86%) of our
patients with pleural metastasis, and the comparable
findings in the control group can prove the specificity of
the CT findings, as we have suggested before. Third, we
didn’t perform a comparative analysis for the predictability
of the CT findings on the 10-mm thick sections and the
thinner sections, although all of our study patients
underwent a limited number of thin-section scanning.
However, we can suggest that the thinner section images
showed subtle pleural changes better and they can
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improve the diagnostic confidence and detectability of
subtle pleural metastasis.
We can conclude that adenocarcinoma is the most
common histologic type of lung cancer to cause pleural
metastasis without or with a small amount of pleural
effusion. If there are any subtle pleural abnormalities such
as nodularity or focal pleural thickening on the preopera-
tive chest CT scans of patients with primary lung cancer,
one should consider the possibility of pleural metastasis
even though there is only a small amount of associated
pleural effusion or perhaps it is absent all together. Further
preoperative diagnostic evaluation that includes PET, PET-
CT scanning, thoracoscopic pleural biopsy or pleural
lavage with cytology may be helpful to avoid unnecessary
thoracotomy in these patients and it can also help reduce
the hospital mortality.
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